Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness and Safety of Methylene Blue for Prevention of Postoperative Neurocognitive Disorders in Patients Undergoing Pancreatic Tumor Surgery: A Prospective Randomized Controlled Clinical Trial

NCT04529265 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT04529265
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04529265 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness and Safety of Methylene Blue for Prevention of Postoperative Neurocognitive Disorders in Patients Undergoing Pancreatic Tumor Surgery: A Prospective Randomized Controlled Clinical Trial
Lead sponsor
Fudan University
Phase
Not applicable
Overall status
Completed
Start date
May 1, 2021
Completion date
December 30, 2024
Enrollment
314 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

postoperative delirium